Dow Down 0.09% Nasdaq Up 0.25%

Antares Pharma Inc. (ATRS)

-NasdaqCM
2.09 Up 0.01(0.48%) 1:06PM EDT - Nasdaq Real Time Price
Prev Close:2.08
Open:2.08
Bid:2.10 x 4900
Ask:2.11 x 2600
1y Target Est:5.63
Beta:0.55
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.05 - 2.12
52wk Range:1.87 - 5.15
Volume:515,112
Avg Vol (3m):1,293,020
Market Cap:272.68M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ATRS

Comparison

Symbol% ChgMkt Cap
ATRSUp 0.48%272.68M
BDXDown 0.29%22.48B
BJCTUp 2.78%5.99M

Key Statistics

Forward P/E (1 yr):35.08
P/S (ttm):12.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback